Buy with no RX

FabiSpray: Pricing and Availability in the Indian Market

•

Article Plan⁚ FabiSpray⁚ Pricing and Availability in the Indian Market

Pricing Information

FabiSpray‚ the Nitric Oxide Nasal Spray (NONS) developed by Glenmark Pharmaceuticals‚ is currently priced at Rs 850 per unit in the Indian market.​ This price includes the entire cost of treatment for a patient with COVID-19. The recommended dosage for mild COVID-19 treatment involves two sprays in each nostril‚ administered six times a day for a duration of 7 days.​ The pricing of FabiSpray is considered nominal in India compared to other countries‚ making it an affordable and accessible option for patients in need of treatment.​

Market Availability

FabiSpray‚ the innovative Nitric Oxide Nasal Spray (NONS) developed by Glenmark Pharmaceuticals‚ has been made available in the Indian market. Following the necessary approvals granted under the government’s accelerated approval process‚ FabiSpray has been launched in India for the treatment of adult COVID-19 patients at high risk of disease progression.​ The product is priced at Rs 850 per unit‚ covering the entire cost of treatment for a patient.​ This pricing strategy aims to make FabiSpray accessible and affordable to those in need of treatment in the Indian market.​

9 responses to “FabiSpray: Pricing and Availability in the Indian Market”

  1. Victoria Avatar
    Victoria

    The pricing and availability information provided for FabiSpray offers valuable insights for individuals in the Indian market who may be considering this Nitric Oxide Nasal Spray for COVID-19 treatment.

    Reply
  2. Isabella Avatar
    Isabella

    The pricing transparency for FabiSpray is commendable, as it allows patients to understand the costs involved in their treatment and make informed decisions regarding their healthcare.

    Reply
  3. Ava Avatar
    Ava

    The recommended dosage of two sprays in each nostril, six times a day for 7 days, provides a clear guideline for patients on how to use FabiSpray effectively for mild COVID-19 treatment.

    Reply
  4. Sophia Avatar
    Sophia

    The pricing information provided for FabiSpray in the Indian market is clear and informative, detailing the cost per unit and the recommended dosage for COVID-19 treatment.

    Reply
  5. Ethan Avatar
    Ethan

    It is beneficial to know that the Rs 850 price per unit of FabiSpray covers the entire treatment cost for a patient with COVID-19, making it easier for individuals to budget for their medical expenses.

    Reply
  6. Leo Avatar
    Leo

    The recommended dosage regimen for FabiSpray aligns with standard medical practices for COVID-19 treatment, ensuring that patients receive the appropriate amount of medication for their recovery.

    Reply
  7. Oliver Avatar
    Oliver

    The detailed pricing and dosage information provided for FabiSpray in the Indian market demonstrates a commitment to clarity and accessibility for patients seeking treatment for COVID-19.

    Reply
  8. Nathan Avatar
    Nathan

    The pricing strategy for FabiSpray seems reasonable considering the comprehensive coverage it offers for the treatment of COVID-19, which can help in ensuring access to affordable healthcare solutions.

    Reply
  9. Grace Avatar
    Grace

    The pricing structure of FabiSpray, with a fixed price for the entire treatment duration, simplifies the financial aspect of seeking medical care for COVID-19, which can be a relief for many patients.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *